Suyin Detoxification Prescription Regulates the Klotho and ERK/NF-κB Signaling Pathways to Alleviate Renal Injury

Lianghui Shu1,2, Li Quan1, Yanping Wang3

  • 1No.1 Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.

PubMed

Insights

Traditional Chinese medicine Suyin detoxification prescription (SDP) shows renoprotective effects in chronic kidney disease (CKD) models. SDP modulates Klotho protein and the ERK/NF-κB pathway, reducing renal fibrosis and inflammation.

Area of Science:

  • Nephrology
  • Pharmacology
  • Traditional Chinese Medicine

Background:

  • Chronic Kidney Disease (CKD) involves irreversible kidney damage due to nephrotoxic substance accumulation.
  • The "Kidney Toxicity" theory offers potential therapeutic targets for CKD.
  • Traditional Chinese Medicine prescriptions like Suyin detoxification prescription (SDP) are explored for renoprotective effects.

Purpose of the Study:

  • To investigate the efficacy of SDP in a murine model of unilateral ureteral obstruction (UUO)-induced kidney injury.
  • To elucidate the molecular mechanisms underlying SDP's renoprotective effects, focusing on Klotho and the ERK/NF-κB signaling pathway.

Main Methods:

  • Established a murine UUO model and treated with SDP.
  • Assessed protein expression (Klotho, VEGF, NF-κB, ERK1/2, α-SMA) using immunohistochemistry, RT-qPCR, and Western Blot.
  • Investigated Klotho's role in human umbilical vein endothelial cells (HUVECs) via protein knockdown.

Main Results:

  • UUO induced renal fibrosis, decreasing Klotho and VEGF, while increasing pNF-κB, pERK1/2, and α-SMA.
  • High-dose SDP treatment reversed these changes in UUO mice, showing statistically significant differences (p<0.05).
  • Klotho knockdown in HUVECs suggested its role in SDP's renoprotection via regulating the ERK/NF-κB pathway.

Conclusions:

  • SDP demonstrates significant renoprotective effects in a murine kidney fibrosis model.
  • SDP's mechanism involves upregulating Klotho protein expression, thereby modulating the ERK/NF-κB signaling pathway.
  • This study advances the understanding of "Kidney Toxicity" pathogenesis and "Kidney Detoxification" therapeutic approaches.

Related Concept Videos

NF-&#954;B-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
439
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
334
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
60